Can B Corp. completes holding company reorganization; becomes subsidiary of Nascent Pharma Holdings

Can B Corp

On Oct 25, 2024, Can B merged with Nascent Merger Sub, becoming wholly owned subsidiary of Nascent Pharma Holdings.
Each share of Can B stock automatically converted into an equivalent corresponding share of Nascent stock with same rights.
Reorganization conducted under FBCA Section 607.11045 without stockholder vote; no gain/loss for tax purposes.
Can B filed Form 15 to deregister its shares; Nascent becomes successor issuer under Exchange Act.
Nascent assumed Can B's 2021 Incentive Stock Option Plan and all outstanding stock options, converted on same terms.

item 1.01 item 3.01 item 3.03 item 5.03 item 5.02 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.